Abstract:Abstract Objective Unresectable colorectal cancer liver metastasis (CRLM) remains a challenging obstacle that often prevents curative treatment. In this study, we retrospectively analyzed the efficacy and safety of high‐intensity focused ultrasound (HIFU) as a local adjuvant therapy for systemic chemotherapy for patients with unresectable CRLM. HIFU is a noninvasive method previously demonstrated as efficacious for various solid malignancies. Methods Propensity score matching was used for the combination therapy group (HIFU group, n = 59) and the observation group receiving systemic therapy only (No‐HIFU group, n = 59). In addition, the survival benefit, adverse effects, and factors affecting prognosis following HIFU were evaluated. Results The disease control rate was 77.9% and 62.7%, and the objective remission rate was 18.9% and 6.8% in the HIFU and non‐HIFU groups, respectively. The survival analysis showed that median progression‐free survival (mPFS) was 12.0 months and 11.0 months for the HIFU and non‐HIFU groups, respectively ( p = 0.002). The univariate and multivariate analysis showed that pre‐treatment colorectal cancer liver metastasis lesion size was significantly associated with mPFS. In addition, patients that received a combination treatment for CRLM lesions <5.0 cm had a longer mPFS when compared to those receiving systemic therapy alone (13.0 months vs. 11.0 months, p = 0.001). In the HIFU group, patients with lesions <5.0 cm had a longer mPFS than patients with lesions ≥5.0 cm (13.0 months vs. 10.0 months, p = 0.04) (Figure 3B,C). Most treatment‐related adverse events observed in both groups were grade 1–2. Only four cases (6.8%) of grade 1–2 skin burns were observed in patients in the HIFU group; no other statistically significant adverse events were observed. Conclusions Our study showed that HIFU ablation targeting unresectable CRLM alongside systemic therapy safely and significantly improved local control rates and prolonged mPFS, especially for lesions smaller than 5.0 cm.

Preliminary experience using high intensity focused ultrasound for treating liver metastasis from colon and stomach cancer

Therapeutic effectiveness of high-intensity focused ultrasound (HIFU) ablation in patients with unresectable hepatocellular carcinoma.

HIFU for the treatment of difficult colorectal liver metastases with unsuitable indications for resection and radiofrequency ablation: a phase I clinical trial

First clinical experience of intra-operative high intensity focused ultrasound in patients with colorectal liver metastases: a phase I-IIa study

The Efficacy Of A New High-Intensity Focused Ultrasound Therapy For Metastatic Pancreatic Cancer

Effect of High Intensity Focused Ultrasound on the Patients with Hepatocellular Carcinoma:Preliminary Report

Effectiveness and safety of ultrasound-guided high-intensity focused ultrasound ablation for the treatment of colorectal cancer liver metastases

High intensity focused ultrasound ablation for patients with inoperable liver cancer.

Clinical effects of high intensity focused ultrasound in treatment of advanced liver cancer: analysis of 254 cases

HIFU for the treatment of gastric cancer with liver metastases with unsuitable indications for hepatectomy and radiofrequency ablation: a prospective and propensity score-matched study

High-intensity focused ultrasound ablation combined with immunotherapy for treating liver metastases: A prospective non-randomized trial

Complications of high intensity focused ultrasound in patients with recurrent and metastatic abdominal tumors

High‐intensity focused ultrasound ablation combined with systemic therapy for unresectable colorectal cancer liver metastasis: A propensity score‐matched analysis

Safety evaluation of high-intensity focused ultrasound in patients with pancreatic cancer.

Safety and efficacy of high-intensity focused ultrasound in pancreatic cancer.

High-intensity focused ultrasound for treatment of advanced malignant tumors located in the walls of chest and abdomen: a preliminary report

Early Clinical Experience Using High Intensity Focused Ultrasound for Palliation of Inoperable Pancreatic Cancer

Multidisciplinary Treatment with Chemotherapy, Targeted Drug, and High-Intensity Focused Ultrasound in Advanced Pancreatic Carcinoma

Long-Term Outcome of High-Intensity Focused Ultrasound in Advanced Pancreatic Cancer

[High intensity focused ultrasound alone for malignant solid tumors]

Extracorporeal high intensity focused ultrasound in the treatment of patients with solid malignancy